New weekly update with 2 purchases.
#dividend
#dividends
#dividende
#stocks
#stock
#invest
#investing
#etf
#etfs
$JNJ (+0,34 %)
$PFE (+0,73 %)
$ABBV (-0,25 %)
$LLY (-0,47 %)
$MRK (+0,58 %)
Puestos
336Bought 4 shares of Johnson&Johnson $JNJ (+0,34 %) today at an average price of $153,52 including transaction costs.
I currently own 22 shares. This gives me an annual dividend of approximately €101 per year.
This was bought with the money on Etoro received from sold shares and received dividends, I still have to spend the weekly €250
#dividend
#dividends
#dividende
#invest
#stocks
#stock
#invest
#investing
Is $JNJ (+0,34 %) a tubular failure
what do you think
Hello my dears...
There have been adjustments to the Sina 40
Out:
$JNJ (+0,34 %)
$ALV (+1,02 %)
$CS (+0,24 %)
$NVDA (+1,32 %)
$7974 (+1,85 %)
$ULVR (+0,09 %)
$NFLX (+1,44 %)
NVIDIA only 50%
apart from j+J, there was considerable profit-taking in some cases (I think 25% is comparatively high for a company like Unilever)
In:
$ANET (+0,79 %)
$ORCL (+1,77 %)
$6857 (+2,28 %)
$AVGO (+3,51 %)
$TXN (+1,6 %)
$COST (-0,7 %)
Stocked up:
The remaining cash is € 2330, which will remain there for the time being. Currently the Sinas is 40, therefore only one Sinas 39. Let's see where the cash will then go in number 40
PS: the chart has been completely messed up by the adjustments. We were actually at 2.71 % 1 Y
The ongoing lawsuits over allegedly carcinogenic talcum powder products have put Johnson under pressure.
A US federal judge has refused to resolve the matter via insolvency proceedings.
The financial risk at Johnson is high, new uncertainty in the strategic direction.
Johnson the new Bayer $BAYN (+0,48 %) and 3M $MMM (+1,13 %) ?
Bottomless pit, the share has been in a volatile downward trend since 2022. Once again, the upper boundary line was not broken.
Principales creadores de la semana